09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/
Related
California law typically frowns on contracts that restrict a person's ability to engage in trade for...
Read More >
In a development sure to be welcomed by employers, the U.S. Department of Labor (DOL) issued revised...
Read More >
Over the past several weeks, the COVID-19 coronavirus outbreak has shaken global markets and caused ...
Read More >
Last week, the U.S. Department of Justice ("DOJ") launched the Procurement Collusion Strike Force ("...
Read More >
The USDA’s Rural Housing Service (RHS) recently issued a final rule, pushing back from August 21, 2...
Read More >
On September 25, 2019, we reminded clients that the Diversity Visa Lottery would be open from Octobe...
Read More >